NFKB1 and digestive system neoplasm: In inflammation-associated cancers like hepatocellular carcinoma and gastrointestinal tumors, NF-κB promotes tumorigenesis by facilitating the accumulation of mutations through reactive oxygen species (ROS) production and recruiting tumor-supportive immune cells.